| Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies SN Khan, AM Jankowska, R Mahfouz, AJ Dunbar, Y Sugimoto, N Hosono, ... Leukemia 27 (6), 1301-1309, 2013 | 165 | 2013 |
| A multifunctional DNA-binding protein that promotes the formation of serum response factor/homeodomain complexes: identity to TFII-I DA Grueneberg, RW Henry, A Brauer, CD Novina, V Cheriyath, AL Roy, ... Genes & development 11 (19), 2482-2493, 1997 | 158 | 1997 |
| Emerging roles of FAM14 family members (G1P3/ISG 6–16 and ISG12/IFI27) in innate immunity and cancer V Cheriyath, DW Leaman, EC Borden Journal of Interferon & Cytokine Research 31 (1), 173-181, 2011 | 136 | 2011 |
| TFII-I Enhances Activation of the c-fosPromoter through Interactions with Upstream Elements DW Kim, V Cheriyath, AL Roy, BH Cochran Molecular and cellular biology 18 (6), 3310-3320, 1998 | 136 | 1998 |
| Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton’s tyrosine kinase CD Novina, S Kumar, U Bajpai, V Cheriyath, K Zhang, S Pillai, HH Wortis, ... Molecular and cellular biology, 1999 | 131 | 1999 |
| Identification of TFII-I as the endoplasmic reticulum stress response element binding factor ERSF: its autoregulation by stress and interaction with ATF6 R Parker, T Phan, P Baumeister, B Roy, V Cheriyath, AL Roy, AS Lee Molecular and cellular biology 21 (9), 3220-3233, 2001 | 130 | 2001 |
| G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells V Cheriyath, KB Glaser, JF Waring, R Baz, MA Hussein, EC Borden The Journal of clinical investigation 117 (10), 3107-3117, 2007 | 124 | 2007 |
| Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene … S Vijayaraghavalu, JK Dermawan, V Cheriyath, V Labhasetwar Molecular pharmaceutics 10 (1), 337-352, 2013 | 101 | 2013 |
| Combinations of DNA methyltransferase and histone deacetylase inhibitors induce DNA damage in small cell lung cancer cells: correlation of resistance with IFN-stimulated gene … W Luszczek, V Cheriyath, TM Mekhail, EC Borden Molecular cancer therapeutics 9 (8), 2309-2321, 2010 | 98 | 2010 |
| Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL SI Bae, V Cheriyath, BS Jacobs, FJ Reu, EC Borden Oncogene 27 (4), 490-498, 2008 | 88 | 2008 |
| G1P3, an interferon-and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer V Cheriyath, MA Kuhns, BS Jacobs, P Evangelista, P Elson, ... Oncogene 31 (17), 2222-2236, 2012 | 83 | 2012 |
| TFII-I regulates Vβ promoter activity through an initiator element V Cheriyath, CD Novina, AL Roy Molecular and cellular biology, 1998 | 80 | 1998 |
| G1P3 (IFI6), a mitochondrial localised antiapoptotic protein, promotes metastatic potential of breast cancer cells through mtROS V Cheriyath, J Kaur, A Davenport, A Khalel, N Chowdhury, L Gaddipati British journal of cancer 119 (1), 52-64, 2018 | 68 | 2018 |
| Alternatively spliced isoforms of TFII-I: complex formation, nuclear translocation, and differential gene regulation V Cheriyath, AL Roy Journal of Biological Chemistry 275 (34), 26300-26308, 2000 | 68 | 2000 |
| c-Src-dependent transcriptional activation of TFII-I V Cheriyath, ZP Desgranges, AL Roy Journal of Biological Chemistry 277 (25), 22798-22805, 2002 | 66 | 2002 |
| Regulation of TFII-I activity by phosphorylation CD Novina, V Cheriyath, AL Roy Journal of Biological Chemistry 273 (50), 33443-33448, 1998 | 58 | 1998 |
| Structure-function analysis of TFII-I: roles of the N-terminal end, basic region, and I-repeats V Cheriyath, AL Roy Journal of Biological Chemistry 276 (11), 8377-8383, 2001 | 49 | 2001 |
| Potentiation of apoptosis by histone deacetylase inhibitors and doxorubicin combination: cytoplasmic cathepsin B as a mediator of apoptosis in multiple myeloma V Cheriyath, MA Kuhns, ME Kalaycio, EC Borden British journal of cancer 104 (6), 957-967, 2011 | 47 | 2011 |
| Proteasome inhibitors in the clinical setting: benefits and strategies to overcome multiple myeloma resistance to proteasome inhibitors V Cheriyath, BS Jacobs, MA Hussein Drugs in R & D 8, 1-12, 2007 | 37 | 2007 |
| Single step isolation of plant RNA. C Venugopalan, HC Kapoor | 25 | 1997 |
